Gene · 5451
Papers3,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage. | Nature | 2022 | 35576971 | PubTator, text mining | PubMed |
| Long-Distance Repression by Human Silencers: Chromatin Interactions and Phase Separation in Silencers. | Cells | 2022 | 35563864 | PubTator, text mining | PubMed |
| HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation. | Int J Mol Sci | 2022 | 35563334 | PubTator, text mining | PubMed |
| The interaction between long non-coding RNA LINC01564 and POU2F1 promotes the proliferation and metastasis of gastric cancer. | J Transl Med | 2022 | 35562740 | PubTator, text mining | PubMed |
| Differential expression analysis of genes and long non-coding RNAs associated with KRAS mutation in colorectal cancer cells. | Sci Rep | 2022 | 35562390 | PubTator, text mining | PubMed |
| Lutetium Lu 177 Vipivotide Tetraxetan: First Approval. | Mol Diagn Ther | 2022 | 35553387 | PubTator, text mining | PubMed |
| CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives. | Theranostics | 2022 | 35547744 | PubTator, text mining | PubMed |
| The Emergence of a New Isoform of POU2F1 in Primates through the Use of Egoistic Mobile Genetic Elements. | Dokl Biochem Biophys | 2022 | 35538289 | PubTator, text mining | PubMed |
| 5-Azacytidine Suppresses the Expression of Tissue-Specific Oct-1 Isoform in Namalwa Burkitt's Lymphoma Cell Culture. | Dokl Biochem Biophys | 2022 | 35538282 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis. | Clin Pharmacol Ther | 2022 | 35510337 | PubTator, text mining | PubMed |
| Development and application of a pediatric mechanistic kidney model. | CPT Pharmacometrics Syst Pharmacol | 2022 | 35506351 | PubTator, text mining | PubMed |
| Sex-specific extracellular matrix remodeling during early adipogenic differentiation by gestational bisphenol A exposure. | Chemosphere | 2022 | 35504463 | PubTator, text mining | PubMed |
| Editorial: The Role of Steroid Hormones and Growth Factors in Cancer. | Front Cell Dev Biol | 2022 | 35493105 | PubTator, text mining | PubMed |
| In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia. | Pharm Res | 2022 | 35484370 | PubTator, text mining | PubMed |
| Effective biomarkers and therapeutic targets of nerve-immunity interaction in the treatment of depression: an integrated investigation of the miRNA-mRNA regulatory networks. | Aging (Albany NY) | 2022 | 35468096 | PubTator, text mining | PubMed |
| Machine learning assisted analysis of breast cancer gene expression profiles reveals novel potential prognostic biomarkers for triple-negative breast cancer. | Comput Struct Biotechnol J | 2022 | 35465161 | PubTator, text mining | PubMed |
| Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy. | Int J Mol Sci | 2022 | 35457081 | PubTator, text mining | PubMed |
| A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer. | Pharmaceuticals (Basel) | 2022 | 35455439 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5451/papers?page=22